tiprankstipranks
AstraZeneca announces results from interim analysis of ECHO Phase III trial
PremiumThe FlyAstraZeneca announces results from interim analysis of ECHO Phase III trial
7d ago
AstraZeneca put volume heavy and directionally bearish
PremiumThe Fly
AstraZeneca put volume heavy and directionally bearish
8d ago
AstraZeneca Shares Voting Rights Update
PremiumCompany Announcements
AstraZeneca Shares Voting Rights Update
8d ago
AIM ImmunoTech announces evaluation of first dose level in Phase 1b/2 study
PremiumThe FlyAIM ImmunoTech announces evaluation of first dose level in Phase 1b/2 study
10d ago
AstraZeneca and  Daiichi Sankyo’s ENHERTU improves PFS in HER2-low
PremiumThe Fly
AstraZeneca and Daiichi Sankyo’s ENHERTU improves PFS in HER2-low
10d ago
AstraZeneca reports results from DESTINY-Breast06 Phase 3 trial
PremiumThe Fly
AstraZeneca reports results from DESTINY-Breast06 Phase 3 trial
10d ago
AstraZeneca’s Q1 2024: Revenue and Dividend Leap
PremiumCompany AnnouncementsAstraZeneca’s Q1 2024: Revenue and Dividend Leap
14d ago
AstraZeneca backs FY24 core EPS view up low double-digit to low teens percentage
PremiumThe Fly
AstraZeneca backs FY24 core EPS view up low double-digit to low teens percentage
14d ago
AstraZeneca reports Q1 core EPS $2.06, consensus $1.22
PremiumThe Fly
AstraZeneca reports Q1 core EPS $2.06, consensus $1.22
14d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100